Graham Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,358
| Closed | -$205K | – | 1249 |
|
|
2024
Q3 | $205K | Sell |
4,358
-951
| -18% | -$44.7K | ﹤0.01% | 872 |
|
|
2024
Q2 | $287K | Buy |
+5,309
| New | +$287K | 0.01% | 728 |
|
|
2023
Q3 | – | Sell |
-6,921
| Closed | -$389K | – | 1039 |
|
|
2023
Q2 | $389K | Buy |
+6,921
| New | +$389K | 0.01% | 605 |
|
|
2022
Q3 | – | Sell |
-10,667
| Closed | -$648K | – | 1094 |
|
|
2022
Q2 | $648K | Buy |
10,667
+6,239
| +141% | +$379K | 0.03% | 575 |
|
|
2022
Q1 | $277K | Buy |
+4,428
| New | +$277K | 0.01% | 743 |
|